Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Director/PDMR Shareholding

1 Oct 2020 09:42

RNS Number : 7919A
Wilmington PLC
01 October 2020
 

1 October 2020

Wilmington plcDirector/PDMR Shareholding

On 30 September 2020, nil cost awards over 997,445 ordinary shares in Wilmington plc (the "Company") and options with a per share exercise price of £1.225 over 443,572 ordinary shares in the Company were granted under the Wilmington Performance Share Plan 2017 (the "Plan") to employees of the Company and its subsidiaries, of which the following nil cost awards were made to Directors of the Company and other Persons Discharging Managerial Responsibilities ("PDMRs"):

 

Name of Director/PDMR

Number of shares under the Award

Mark Milner (Executive Director)

285,714

Richard Amos (Executive Director)

159,596

Tamara Kahn (PDMR)

91,837

Thomas Mount (PDMR)

67,347

Richard Shamsi (PDMR)

102,041

 

No consideration was paid for the grant of the awards. The vesting of the awards and options is subject to the satisfaction of performance conditions, which will be assessed over three years. Having regard to the uncertainty caused by the Covid-19 pandemic, the Remuneration Committee has decided to defer setting exact performance measures and targets at this point, and these will be set by the latest at the mid-point of financial year 2021. The performance measures and targets for the Executive Directors' will be confirmed in the Directors' Remuneration Report for the 2021 financial year.

Each award and option is granted subject to a condition that the Remuneration Committee may reduce the extent of vesting if and to the extent it considers that any of the value of the award or option represents a windfall gain caused by the impact on the price of a share of the Covid-19 pandemic.

The awards granted to the Executive Directors and other PDMRs are subject to an additional condition that ordinarily all of the shares acquired (after sales to cover tax) must be retained until the second anniversary of the vesting date.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

For further information, please contact:

Wilmington plc 020 7422 6800

Richard Amos

Chief Financial Officer and Company Secretary

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and networking in Risk & Compliance, Healthcare and Professional areas. Wilmington employs close to 1,000 people and sells to around 120 countries. Wilmington is a premium listed company on the main market of the London Stock Exchange.

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

a)

Name

Mark Milner

2.

Reason for the notification

 

a)

Position /status

Chief Executive Officer

b)

Initial notification / amendment 

Initial Notification

3.

Details of the Issuer 

a)

Name

Wilmington plc

 

b)

LEI code

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares in Wilmington plc

ISIN: GB0009692319

 

b)

 

Nature of the transaction

 

Grant of award over Ordinary Shares under the Company's Performance Share Plan 2017

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil Cost

285,714

d)

Aggregated information

Aggregated volume

Price

 

 

N/A

 

 

e)

Date of the transaction

30 September 2020

 

f)

 

Place of the transaction

 

Outside a trading venue

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

a)

Name

Richard Amos

2.

Reason for the notification

 

a)

Position /status

Chief Financial Officer

b)

Initial notification / amendment 

Initial Notification

3.

Details of the Issuer 

a)

Name

Wilmington plc

 

b)

LEI code

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares in Wilmington plc

ISIN: GB0009692319

 

b)

 

Nature of the transaction

 

Grant of award over Ordinary Shares under the Company's Performance Share Plan 2017

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil Cost

159,596

d)

Aggregated information

Aggregated volume

Price

 

 

N/A

 

 

e)

Date of the transaction

30 September 2020

 

f)

 

Place of the transaction

 

Outside a trading venue

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

a)

Name

Richard Shamsi

2.

Reason for the notification

 

a)

Position /status

Chief Operating Officer

b)

Initial notification / amendment 

Initial Notification

3.

Details of the Issuer 

a)

Name

Wilmington plc

 

b)

LEI code

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares in Wilmington plc

ISIN: GB0009692319

 

b)

 

Nature of the transaction

 

Grant of award over Ordinary Shares under the Company's Performance Share Plan 2017

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil Cost

102,041

d)

Aggregated information

Aggregated volume

Price

 

 

N/A

 

 

e)

Date of the transaction

30 September 2020

 

f)

 

Place of the transaction

 

Outside a trading venue

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

a)

Name

Tamara Kahn

2.

Reason for the notification

 

a)

Position /status

Divisional Director

b)

Initial notification / amendment 

Initial Notification

3.

Details of the Issuer 

a)

Name

Wilmington plc

 

b)

LEI code

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares in Wilmington plc

ISIN: GB0009692319

 

b)

 

Nature of the transaction

 

Grant of award over Ordinary Shares under the Company's Performance Share Plan 2017

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil Cost

91,837

d)

Aggregated information

Aggregated volume

Price

 

 

N/A

 

 

e)

Date of the transaction

30 September 2020

 

f)

 

Place of the transaction

 

Outside a trading venue

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

a)

Name

Thomas Mount

2.

Reason for the notification

 

a)

Position /status

Chief Technology Officer

b)

Initial notification / amendment 

Initial Notification

3.

Details of the Issuer 

a)

Name

Wilmington plc

 

b)

LEI code

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares in Wilmington plc

ISIN: GB0009692319

 

b)

 

Nature of the transaction

 

Grant of award over Ordinary Shares under the Company's Performance Share Plan 2017

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil Cost

67,347

d)

Aggregated information

Aggregated volume

Price

 

 

N/A

 

 

e)

Date of the transaction

30 September 2020

 

f)

 

Place of the transaction

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMBBPTMTIMMBM
Date   Source Headline
17th Apr 202611:20 amRNSHolding(s) in Company
15th Apr 20263:56 pmRNSBoard changes
15th Apr 202611:21 amRNSSave As You Earn Options
11th Mar 202611:00 amRNSDirector Declaration
11th Mar 202611:00 amRNSDirector Declaration
26th Feb 20267:00 amRNSHalf-year Financial Report
11th Feb 20262:44 pmRNSNotice of half year-end results
21st Jan 202611:19 amRNSNotice of Half Year Results
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
5th Dec 20259:56 amRNSAcquisition of Conversia completed
28th Nov 20254:23 pmRNSDirector/PDMR Shareholding
28th Nov 202511:22 amRNSAcquisition of Conversia cleared to complete
25th Nov 20259:19 amRNSResult of AGM
10th Nov 20255:54 pmRNSDirectorate change
1st Oct 20252:51 pmRNSDirector/PDMR Shareholding
1st Oct 20252:49 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights
22nd Sep 202512:48 pmRNSDirector/PDMR Shareholding- Replacement
22nd Sep 202511:52 amRNSDirector/PDMR Shareholding
22nd Sep 20257:00 amRNSFinancial results for the year ended 30 June 2025
5th Sep 202510:58 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSNotice of year-end results
29th Aug 202511:07 amRNSHolding(s) in Company
12th Aug 20257:03 amRNSProposed acquisition of Conversia
12th Aug 20257:00 amRNSDirector Declaration
1st Aug 20257:00 amRNSAppointment of Joint Corporate Broker
30th Jul 20257:00 amRNSStatement in relation to a potential acquisition
23rd Jul 20257:00 amRNSTrading Statement
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20259:00 amRNSDirector/PDMR Shareholding
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20259:30 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.